Results 111 to 120 of about 2,368 (193)

First- and Second-Year Outcomes After Nirsevimab Immunization

Importance The consistency of nirsevimab effectiveness across consecutive seasons and its broader clinical protective effects remain to be fully characterized.
Epiphane Kolla, Amélie Gabet, Ludovic Tréluyer, Marie-Joelle Jabagi, Antoine Rachas, Marion Bertrand, Valérie Olié, Mahmoud Zureik, Olivia Weill   +8 more
core   +1 more source

Impact du nirsevimab sur les hospitalisations pour bronchiolites à VRS au CHU de Clermont-Ferrand durant l'hiver 2023-2024

Contexte : le virus respiratoire syncytial (VRS) est la cause la plus fréquente de bronchiolite chez les nourrissons pouvant causer des atteintes graves allant jusqu’au décès.
Couteau, Lorène
core   +1 more source

Beyond Efficacy: Policy, Delivery, and Equity Determinants of Long-Acting Monoclonal Antibody Uptake for Infant RSV Prevention-A WAidid Consensus Document. [PDF]

Vaccines (Basel)
Esposito S, Abu-Raya B, Eley B, Halasa N, Martinon-Torres F, Mejias A, Spoulou V, Tenenbaum T, Torres JP, Osterhaus A, Ramilo O, Principi N.   +11 more
europepmc   +1 more source

Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis. [PDF]

PLoS Med
Lenglart L, Titomanlio L, Alberti I, Almeida L, Aupiais C, Akyüz Özkan E, Barrett M, Basmaci R, Birbilen A, Borensztajn D, Schönenberger CB, Bressan S, Buonsenso D, Campos T, Castanhinha S, Chiaretti A, Claret G, De Zan F, Durnin S, Fodor L, Gomez B, Greber-Platzer S, Guedj R, Huege A, Leonard F, Maconochie IK, Marlow R, Milani G, Molina Gutierrez MA, Musolino AM, Oostenbrink R, Pucuka Z, Rivière S, Roland D, Rinder MR, Supino MC, Teksam O, Trenchs V, Valtuille Z, Vanda B, Vrijlandt S, Ouldali N, Nijman RG, EPISODES Study Group.   +43 more
europepmc   +1 more source

Real-World Effectiveness of Nirsevimab Against RSV-LRTI and Bronchiolitis Hospitalization: Results from the 2024-2025 Italian Universal Immunization Campaign in Newborns. [PDF]

Viruses
Auriti C, Gizzi C, Riccò M, Bellù R, Giuffrè M, Fabiano A, Cacace C, Cavicchioli P, Cuttano A, Valerio SD, Germini C, Napolitano M, Paviotti G, Peila C, Perrone S, Pesce S, Scarpelli G, Scutti G, Spanedda G, Staffler A, Agosti M, On Behalf Of The Italian Working Group On Rsv Prophylaxis Of Italian Society Of Neonatology.   +21 more
europepmc   +1 more source

Nirsevimab rollout in the Gulf Cooperation Council, scoping review protocol

Protocol for a PRISMA-ScR scoping review of nirsevimab implementation across the six Gulf Cooperation Council countries during the 2024 to 2025 and 2025 to 2026 RSV seasons, with cost-effectiveness modeling for Kuwait, Qatar, Bahrain, and Oman ...
Rabia Shah
core  

Comment on Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. <i>Vaccines</i> 2026, <i>14</i>, 411. [PDF]

Vaccines (Basel)
Hodges EN, Ghemmouri M, Neary MP, Gabriel V, Ottaviano C, Mari K, Ottobrino V, Chit A, Domachowske J, Yarnoff B, Musci R, Krilov LR.   +11 more
europepmc   +1 more source

Evaluation of Nirsevimab and hRSV Severity Risk Factors on hRSV Admissions

Human Respiratory Syncytial Virus (hRSV) is a common respiratory pathogen, primarily affecting infants and young children. In the United States, hRSV is a leading cause of hospitalization in this age group. Currently, there is no treatment for acute hRSV.
Ogrin, Sara, Leffler, Luke, Grofvert, John   +2 more
core  

Respiratory Pathogen Co-Detection in Hospitalized Infants with Bronchiolitis and Implementation of Universal Nirsevimab Immunoprophylaxis: A Six-Year Observational Study. [PDF]

Children (Basel)
Serra G, Martorana C, Barbera G, Catania M, Cipolla D, Colomba C, Farruggia P, Giuffrè M, La Malfa G, Greco M, Corsello G.   +10 more
europepmc   +1 more source

Guideline for Weighing of Infants for Nirsevimab Administration.

Purpose To provide a standardised approach to determine the correct Nirsevimab dose for infants attending a catch-up clinic including mobile vaccination clinics: ensuring accurate dosing while avoiding unnecessary ...
Health Protection Surveillance Centre (HPSC)
core